Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2001Cancer

Expression of apoptosis proteins in chronic myelogenous leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

Farhad RavandiFarhad RavandiNihon UniversityHagop M. KantarjianHagop M. KantarjianThe University of Texas MD Anderson Cancer CenterMoshe TalpazMoshe TalpazUniversity of Verona

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ravandi et al. (2001) studied this question.

synapsesocial.com/papers/6a70b9faf44fa9f079de6c97https://doi.org/10.1002/1097-0142(20010601)91:11<1964::aid-cncr1221>3.0.co;2-b
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia1994 · 500 citations
  2. 2Multidrug resistance protein expression in chronic myeloid leukemia1999 · 36 citations
  3. 3BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15;83(12):3835]1994 · 376 citations
  4. 4Fas-Mediated Modulation of Bcr/Abl in Chronic Myelogenous Leukemia Results in Differential Effects on Apoptosis1998 · 42 citations
  5. 5Fas-Mediated Modulation of Bcr/Abl in Chronic Myelogenous Leukemia Results in Differential Effects on Apoptosis1998 · 7 citations